According to the latest report by IMARC Group, titled, “Ablation Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027“, The global ablation devices market size reached US$ 4.7 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 9.1 Billion by 2027, exhibiting a growth rate (CAGR) of 11.7% during 2022-2027.
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Ablation devices refer to minimally invasive (MI) medical instruments utilized for the excision or removal of abnormal body tissues for therapeutic purposes. Their commonly used variants include fluid-cooled, temperature-controlled, robotic catheter manipulation and laser ablators, balloon ablation devices, tissue contact and spray probes, etc. These devices operate using various technologies, such as hydrothermal, laser, cryoablation, microwave, ultrasound, etc. They find extensive applications in treating different disorders, including oncological, ophthalmological, gynecological, urological, cardiovascular, etc., as well as in managing several chronic diseases, removing kidney stones and cancerous tumors, managing chronic neck, lower back, and arthritis pain, etc.
Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/ablation-devices-market/requestsample
The surging prevalence of life-threatening diseases, such as cancer, atrial fibrillation, chronic venous insufficiency (CVI), etc., is among the primary factors driving the ablation devices market. Moreover, the growing public awareness towards the increasing availability of effective ablation procedures is further augmenting the product demand. Additionally, the rising adoption of electrophysiology to remove abnormal tissues that cause irregular heart rhythms or cardiac arrhythmia is bolstering the market growth. Furthermore, the development of various innovative products, such as next-generation ablation devices with robotic navigation systems, is also catalyzing the global market. Besides this, the introduction of non-thermal, non-tumescent, and non-sclerosant endovenous variants for effectively treating superficial vein reflux is expected to stimulate the ablation devices market over the forecasted period.
The competitive landscape of the industry has also been examined along with the profiles of the key players.
- Abbott Laboratories
- Angio Dynamics Inc.
- AtriCure Inc.
- Boston Scientific Corporation
- CONMED Corporation
- Elekta AB (publ)
- Johnson & Johnson
- Medtronic plc
- Olympus Corporation
- Smith & Nephew plc.
The report has segmented the market based on device technology, application and end user.
Breakup by Device Technology:
- Radiofrequency Devices
- Laser/Light Ablation
- Ultrasound Devices
- Cryoablation Devices
Breakup by Application:
- Cancer Treatment
- Cardiovascular Disease Treatment
- Ophthalmologic Treatment
- Gynecological Treatment
- Urological Treatment
- Cosmetic Surgery
Breakup by End User:
- Ambulatory Surgical Centers
Breakup by Region:
- North America
- Latin America
- Middle East and Africa
Inquire before buying: https://www.imarcgroup.com/request?type=report&id=4358&flag=F
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800
For more related information visit mbc2030 live